UBS analyst David Lai upgraded Nuvalent (NUVL) to Buy from Neutral with an unchanged price target of $100. The shares have been “beaten down” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback